Drug developer Seaport Therapeutics targets $912 million valuation in US IPO - Reuters

Reuters | April 27, 2026, 6:53 a.m. | Original
Drug developer Seaport Therapeutics targets $912 million valuation in US IPO Reuters
South Africa withdraws AI policy due to fake AI-generated sources - Reuters Big fuel bill, Spirit bailout may upend JetBlue Airways return to profitability - Reuters